Daily Bulletin (9th December, 2019)

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20191209-23

1.Scrip code : 539026
Name : SSPN Finance Limited
Subject : NOTICE OF EXTRAORDINARY GENERAL MEETING OF THE MEMBERS OF SSPN
To consider and approve Issue of Fully Paid Bonus Equity Shares in the ratio of 1:1 To consider and if thought fit, to pass, with or without modification(s)

2.Scrip code : 531633
Name : Lincoln Pharmaceuticals ltd.
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the meeting of Board of Directors of Lincoln Pharmaceuticals Limited (the “Company”) held on today, i.e. December 7, 2019 and considered and decided following business; 1. It is decided to withdraw the Scheme of amalgamation between Lincoln Parenteral Limited (“Transferor Company”) and Lincoln Pharmaceuticals Limited (“Transferee Company”) as approved by the Board of Directors in its meeting held on September 19, 2019 and 2. Approved the Scheme of Amalgamation between Lincoln Parenteral Limited (“Transferor Company”) and Lincoln Pharmaceuticals Limited (“Transferee Company”) (“Scheme”), subject to all requisite approval. The Appointed Date for the Scheme is April 01, 2019.

3.Scrip code : 540725
Name : Share India Securities Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement
This is with reference to the Petition No. CP(CAA) No. 184/ALD of 2019 filed by Share India Securities Limited and Total Securities Limited jointly before the NCLT, Allahabad for approving the Scheme of Amalgamation of Total Securities Limited with Share India Securities Limited. We have received the Formal Order from NCLT and the same has been filed with Registrar of Companies on 09.12.2019, the receipt whereof is attached herewith for your kind reference. Therefore, the Scheme shall stand effective from 09.12.2019.

4.Scrip code : 540975
Name : Aster DM Healthcare Limited
Subject : Announcement under Regulation 30 (LODR)-Acquisition
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 pursuant to acquisition of a step-down subsidiary, Premium Healthcare Limited, UAE. In furtherance to the announcement made by the Company on October 31, 2019 on the Captioned subject the Company through its Subsidiary, Aster DM Healthcare FZC, Completed acquisition of 80% stake in Premium Healthcare Limited, UAE on December 5, 2019 and confirmation received by the Company from Dubai International Financial Centre Authority (DIFCA) on December 08, 2019. In this regard, as per Circular Number CIR/CFD/CMD/4/2015 dated September 09, 2015 pertaining to continuous disclosure requirements for Listed Entities under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Annexure I for your records. We request you to kindly take the above information on record.

5.Scrip code : 532805
Name : Redington (India) ltd.
Subject : Announcement under Regulation 30 (LODR)-Updates on Acquisition
This has reference to our earlier announcements dated 28th July 2016, 22nd December 2016 and 13th September 2018 regarding investments of M/s. ProConnect Supply Chain Solutions Limited (ProConnect), a wholly owned subsidiary of the Company in M/s. Rajprotim Supply Chain Solutions Limited (RCS). We wish to inform you that we have been informed by ProConnect that it had acquired additional 12% stake in RCS. With this acquisition, the total holding of ProConnect in RCS is increased from 88% to 100% and hence pursuant to this acquisition, RCS becomes a wholly owned subsidiary of ProConnect.

6.Scrip code : 532705
Name : Jagran Prakashan Limited
Subject : Corporate Action-Intimation of Buy back
The Board of Directors of the Company, at its meeting held on Monday, December 09, 2019 at 01:30 P.M. which concluded at 02:30 P.M., approved the buyback of the Company”s fully paid-up equity shares. For further details kindly refer the attachment.